BeStock  
Markets › Compare › GENB vs AVLN

GENB vs AVLN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
GENB · Generate Biomedicines$9.54 ▼ 8.00%
AVLN · Avalyn Pharma$28.40 ▼ 1.05%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

7094118142167Apr 30, '26Aug 12, '26Nov 20, '26
  • GENB -24.5%
  • AVLN -3.7%

Head to head

MetricGENBAVLN
Price$9.54$28.40
Change today▼ 8.00%▼ 1.05%
Market cap$1.23B$1.26B
Return, 3 months-46.2%-24.6%
Return, year to date––
Return, 1 year––
P/E (TTM)––
P/B3.23.4
P/E percentile vs own 5y69th74th
Dividend yield––
Revenue growth (YoY, latest qtr)-56.2%–
Net profit growth (YoY)-46.0%-43.3%
Gross margin––
Operating margin-1,382.0%–
Net margin-1,381.8%–
Return on equity-76.4%-25.9%
Analyst target vs. price+172.5%+111.3%
Analyst buy share100%100%
RSI (14)3351
30-day volatility107.6%62.3%
Max drawdown, 1 year-53.2%-40.6%
Trend readStrong downtrendStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AVLN is the largest of the group by market value.
  • AVLN has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top